Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · September 07, 2022

Statins and LVEF Following Doxorubicin Treatment

NEJM Evidence


Additional Info

Disclosure statements are available on the authors' profiles:

NEJM Evidence
Statins and Left Ventricular Ejection Fraction Following Doxorubicin Treatment
NEJM Evid 2022 Aug 18;[EPub Ahead of Print], WG Hundley, R Jr D'Agostino, T Crotts, et al

Further Reading